![]() 布南色林结构式
![]() |
常用名 | 布南色林 | 英文名 | Blonanserin |
---|---|---|---|---|
CAS号 | 132810-10-7 | 分子量 | 367.503 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 540.8±50.0 °C at 760 mmHg | |
分子式 | C23H30FN3 | 熔点 | 117-119°C | |
MSDS | 中文版 美版 | 闪点 | 280.9±30.1 °C | |
符号 |
![]() GHS07 |
信号词 | Warning |
Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.
Clin. Neuropharmacol. 36(6) , 223-38, (2013) Schizophrenia is a serious, chronic, and devastating mental illness with a substantial impact on psychological, physical, social, and economical areas of an individual and society. To treat such critical mental illness, a number of first-generation (typical) ... |
|
Blonanserin in the treatment of delirium.
Psychiatry Clin. Neurosci. 65(4) , 389-91, (2011) The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively revie... |
|
Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
Psychogeriatrics 10(4) , 198-200, (2010) The aim of the present study was to determine the efficacy, side-effects and tolerability of blonanserin for treating refractory behavioural psychological symptoms of dementia (BPSD). The present study was a 12-week, prospective, structured clinical trial of ... |
|
Development and validation of a stability-indicating gas chromatographic method for quality control of residual solvents in blonanserin: a novel atypical antipsychotic agent.
J. Chromatogr. Sci. 50(8) , 727-32, (2012) Blonanserin is a novel atypical antipsychotic agent for the treatment of schizophrenia. Ethyl alcohol, isopropyl alcohol and toluene are utilized in the synthesis route of this bulk drug. A new validated gas chromatographic (GC) method for the simultaneous de... |
|
Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.
Psychiatry Clin. Neurosci. 66(6) , 534-5, (2012)
|
|
Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.
Psychiatry Clin. Neurosci. 66(4) , 370-1, (2012)
|
|
Three cases of schizophrenia showing improvement after switching to blonanserin.
Psychiatry Clin. Neurosci. 65(4) , 396-7, (2011)
|
|
Olfactory reference syndrome treated by blonanserin augmentation.
Psychiatry Clin. Neurosci. 65(2) , 203-4, (2011)
|
|
Neuroleptic malignant syndrome induced by blonanserin.
J. Neuropsychiatry Clin. Neurosci. 23(1) , E13, (2011)
|
|
Case of delirium complicated with pneumonia that improved with blonanserin administration.
Psychiatry Clin. Neurosci. 64(5) , 588-9, (2010)
|